ArticleTranslational cancer research2026
Global hotspots and trends of stereotactic radiotherapy for pancreatic cancer: a bibliometric analysis and visual analysis from 2015 to 2025.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pancreatic cancer (PC) is a highly aggressive malignant tumor with extremely poor prognosis. Most patients are locally advanced or unresectable at the time of diagnosis. Stereotactic body radiotherapy (SBRT) has received extensive attention in this field in recent years due to its advantages of high precision, short course of treatment and low toxicity. However, there is a lack of summary of recent research trends and hotspots. This study aimed to characterize the current status, hotspots, and future directions of this field. Methods: Based on the core collection of Web of Science, we searched relevant publications on SBRT in PC treatment published from January 2015 to December 2025. CiteSpace and VOSviewer were used for bibliometric analysis and visual analysis of publications in this field, covering annual publication trends, countries/regions, institutions, highly cited literatures, authors, journals and keywords. Results: Web of Science Core Collection (WOSCC) included 296 articles from 28 countries. Since 2015, the number of publications on SBRT for PC has increased annually. The United States (USA) was the most productive country, Johns Hopkins University was the leading institution, Conclusions: SBRT has been increasingly studied in PC, focusing on dose and technical optimization. The future development direction will focus on the development and improvement of artificial intelligence (AI) applications, MR-guided adaptive radiotherapy, and combined immune strategy to further improve the survival and quality of life of PC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.